Two cupped hands cradling — warm window light

It starts with a person.

Humanity defines the technology.

01 / 03 Research Evidence, end to end Peer-reviewed health-data science, from question to published result. Opioid research programme →
02 / 03 Education In conversation Teaching and mentorship across clinical practice and higher education.
03 / 03 Build & Design Planned, delivered, validated. Clinical tools, websites, and brand assets, designed and built. AI triage tool →
TRANSLATIONAL
HEALTH Co.
By Dr Jay Gong Clinical academic, health-solution builder

Clinical research and innovations, built for patients.

Selected work → Work with me →

Dr Jay Gong

Clinical academic, health-solution builder.

  • Research. Peer-reviewed health-data science, from question to published result.
  • Education. Teaching and mentorship across clinical practice and higher education.
  • Build & Design. Clinical tools, websites, and brand assets, designed and built.
See the work
Selected work

Projects at a glance.

  1. At-a-glance figure: 1 in 11 after surgery, 1 in 7 after trauma develop persistent opioid use, with a 6.6× downstream mortality multiplier in surgical patients and 2.8× in trauma patients.
    Research

    Persistent opioid use after surgery and trauma

    A national cohort showing that 1 in 11 people develop persistent opioid use after surgery and 1 in 7 after trauma, and that it carries real downstream harm.

    Open case study →
  2. Editorial figure: a literacy column on the left showing three named AI tools (Claude, Perplexity, and custom skills) with their use cases, alongside a four-step skill chain on the right covering clinical question, cited literature, voice-preserving draft, and human ownership.
    Build

    AI in research and teaching

    AI literacy in clinical academia: opinionated tool choice, AI-inclusive assessments built from the inside, and composable skills with the author still in charge of the argument.

    Open case study →
  3. Editorial figure: two columns. On the left, two audit chips covering missing-data and contradiction checks. On the right, three triage bands covering Urgent, Routine (highlighted), and Not accepted.
    Build

    AI-assisted colonoscopy triage tool

    A clinical tool that reads a colonoscopy referral letter and applies New Zealand's national triage guidelines, closing the gap between primary care and the specialist inbox.

    Open case study →
  4. Editorial treatment map: a central asthma node connected to five established treatments in emerald (inhaled steroids, reliever inhalers, long-acting inhalers, biologics, steroid tablets) and one repurposed candidate in clay (metformin, marked as under study).
    Research

    Metformin in asthma: Cochrane review and emulated trial

    A Cochrane review of an old diabetes medicine as a possible treatment for asthma, paired with an emulated-trial analysis to extract causal answers from real-world data.

    Open case study →
View partners →
Dr Jay Gong, smiling, wearing a light blue shirt, in a warm clay-toned interior
About

The clinician who builds.

I'm a hospital pharmacist and pharmacoepidemiologist based at the University of Auckland. My work spans clinical care, real-world health data, and applied AI. The question anchoring all of it is straightforward. Who is harmed by the medicines we prescribe, and how do we use data and technology to prevent that harm?

On the clinical side, that has meant a decade of pharmacy practice and a national cohort programme on persistent opioid use after surgery and trauma. The numbers from that programme (one in eleven after surgery, one in seven after trauma, and a roughly six-fold increase in downstream mortality) now anchor New Zealand's opioid stewardship conversation.

On the technical side, that has meant building the clinical tools that close the loop. A national triage assistant for colonoscopy referrals. A smartphone-and-wearable system that predicts asthma attacks before they arrive. The data infrastructure that ties all of it back to outcomes. Each tool answers a real clinical bottleneck and is validated against the standard of care. I build for regulatory review.

The through-line is the brand thesis: humanity defines the technology. I build for the patient in the bed, the clinician at the desk, and the system that has to make a decision tonight. If your work sits anywhere across that arc (research collaboration, advisory, speaking, or a hard build), I'd like to hear about it.

  • 10+yrs clinical
  • 30+publications
  • $2.9M+funded
Affiliations
Contact

Start a conversation.

Research collaboration, advisory, speaking, and media. Not recruiting outreach or vendor pitches.